Browse by region

World Map Middle East Africa South Asia Asia/Pacific Europe South America North America

Biological safety lock for genetically modified organisms

Scientists have genetically recoded a strain of E. coli to depend on a synthetic amino acid so the bacteria can’t survive outside the lab. The E. coli were also made resistant to two viruses.

J&J Announce Start of Phase 1 Clinical Trial of Ebola Vaccine

Johnson & Johnson this week announced the start of a Phase 1, first-in-human clinical trial of a preventive Ebola vaccine in development at its Janssen Pharmaceutical Companies. The trial is being led by the Oxford Vaccine Group, part of the University of Oxford Department of Paediatrics. Recruitment in the trial is  Read More »

UC Davis Working to Help Speed Ebola Drug Production

Researchers at the University of California, Davis will explore ways to speed production of the Ebola drug with a $200,000 rapid-response grant from the National Science Foundation. Developed by Mapp Biopharmaceutical Inc. of San Diego, in collaboration with the U.S. government and partners in Canada, Zmapp is a cocktail of antibodies  Read More »

Possible Game-Changing Antibiotics from Soil Bacterium

Researchers have found a potential drug to fight the evolving antibiotic crisis, buried just underfoot in the soil in Maine. Named teixobactin, the promising target was discovered by a team led by Kim Lewis of Northeastern University, and has proven effective at killing methicillin-resistant Staphylococcus aureus (MRSA) and Mycobacterium tuberculosis in  Read More »

Jan. 9 news: Measles at Disneyland, e-cigarette regulation, flu tracking